Citizens Reiterates Market Outperform Rating on Solid Biosciences (SLDB)

March 16, 2026 5:03 AM

Citizens analyst Silvan Turkcan reiterated a Market Outperform rating and $15.00 price target on Solid Biosciences (NASDAQ: SLDB).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found